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Mutant KLF1 in Adult Anemic 
Nan Mice Leads to Profound 
Transcriptome Changes and 
Disordered Erythropoiesis
Danitza Nébor1, Joel H. Graber1,2, Steven L. Ciciotte1, Raymond F. Robledo1, Julien Papoin3, 
Emily Hartman3, Kevin R. Gillinder4,5, Andrew C. Perkins4,5, James J. Bieker6, Lionel Blanc  3 & 
Luanne L. Peters1
Anemic Nan mice carry a mutation (E339D) in the second zinc finger of erythroid transcription factor 
KLF1. Nan-KLF1 fails to bind a subset of normal KLF1 targets and ectopically binds a large set of genes 
not normally engaged by KLF1, resulting in a corrupted fetal liver transcriptome. Here, we performed 
RNAseq using flow cytometric-sorted spleen erythroid precursors from adult Nan and WT littermates 
rendered anemic by phlebotomy to identify global transcriptome changes specific to the Nan Klf1 
mutation as opposed to anemia generally. Mutant Nan-KLF1 leads to extensive and progressive 
transcriptome corruption in adult spleen erythroid precursors such that stress erythropoiesis is severely 
compromised. Terminal erythroid differentiation is defective in the bone marrow as well. Principle 
component analysis reveals two major patterns of differential gene expression predicting that defects in 
basic cellular processes including translation, cell cycle, and DNA repair could contribute to disordered 
erythropoiesis and anemia in Nan. Significant erythroid precursor stage specific changes were identified 
in some of these processes in Nan. Remarkably, however, despite expression changes in large numbers 
of associated genes, most basic cellular processes were intact in Nan indicating that developing red cells 
display significant physiological resiliency and establish new homeostatic set points in vivo.
In the inbred semi-dominant mouse model, Nan (neonatal anemia), heterozygotes suffer lifelong anemia due to 
a missense mutation (E339D) in KLF1 (Krüppel-like factor 1)1,2. Homozygotes die in utero (E10-11). Klf1 expres-
sion is restricted to megakaryocyte-erythroid progenitors and erythroid lineage cells where it plays a global role in 
lineage determination and initiating and maintaining the erythroid-specific transcriptome including expression 
of globin, membrane skeleton, heme biosynthetic, iron regulating, and cell cycle genes3–10. Indeed, characteristics 
of both hereditary spherocytosis and thalassemia are evident in adult Nan/+ (hereafter Nan) mice with mem-
brane skeleton defects, decreased expression of adult globin, and increased expression of embryonic globin1,2.
KLF1 is a C2H2 transcription factor with three tandem zinc fingers (ZFs), each recognizing a nucleotide 
triplet in its 9 bp cognate DNA binding site, 5′-CCM-CRC-CCN3,11,12. Glutamic acid at position 339 within ZF2 
interacts with the middle triplet. Despite the conservative amino acid change to aspartic acid, the effect on DNA 
recognition is profound. Previous work1 showed that Nan-KLF1 binds normally to target genes containing gua-
nine at position 5 in the middle triplet but fails to bind, or binds with reduced affinity, to genes containing ade-
nine including β-globin (Hbb), the cell cycle regulator E2F2 (E2f2), and the membrane skeleton protein dematin 
(Dmtn). Notably, the normal Klf1 allele is expressed in Nan erythroid cells. Despite this, expression of genes that 
mutant Nan-KLF1 does not bind is somehow disrupted through an unknown mechanism.
Nan-KLF1 also ectopically binds sites not normally engaged by KLF113,14. In fetal liver, only 18% of 
up-regulated and 52% of down-regulated genes in Nan overlapped known KLF1 targets. ChIPseq confirmed 
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ectopic Nan-KLF1 binding to an altered consensus sequence, CCM-NGC-CCN, with the result that >60% of 
Nan-KLF1 occupied sites do not overlap wild type (WT) KLF1 sites. Ectopic binding contributes to anemia in 
Nan through extrinsic mechanisms15. For example, hepcidin (Hamp) and interferon regulatory factor 7 (Irf7), 
normally expressed in adult liver16 and macrophages17, respectively, show dramatically increased expression in 
Nan fetal liver13 and adult WT spleen and bone marrow15 leading to increased serum hepcidin and interferon 
beta. lncreased hepcidin with markedly decreased erythroferrone, which is not bound by Nan-KLF115, limits iron 
availability18,19. Interferons inhibit erythropoiesis at the BFU- and CFU-E stages20.
Nan is relevant to human erythroid-related disease. Human KLF1 mutations lead to benign defects21,22 and 
anemia, sometimes severe23. For example, a different substitution (E325K) at the position corresponding to Nan 
causes congenital dyserythropoietic anemia (CDA) type IV22. Prior transcriptome studies in Nan focused on fetal 
liver erythroid cells1,13,15. Here, we performed RNAseq in adult spleen erythroid precursors, comparing Nan to 
littermates made anemic by phlebotomy (WT-PHB). The use of anemic WT controls allowed identification of 
expression changes occurring primarily in response to the Nan KLF1 defect. We show that differential expression 
in Nan differs in fetal liver and spleen erythroid cells, that expression variation is driven primarily by precursor 
cell type with mutation effects most prominent in late erythroblasts, and that progression of erythropoiesis is 
significantly impaired. PCA reveals two major patterns of differential gene expression and predicts that defects 
in basic cellular processes (e.g., translation, cell cycle) contribute to anemia in Nan. Indeed, erythroid precursor 
stage specific alterations in some of these processes were identified. Overall, however, despite extensive differ-
ential expression, the basic cellular machinery appears largely intact in Nan, suggesting substantial tolerance to 
transcriptional changes and physiological resiliency in developing red blood cells (RBCs) in vivo.
Results
Distortion of the Nan transcriptome increases during differentiation. Both Klf1 alleles, E339 and 
D339, are expressed in Nan spleen erythroid precursors (Fig. 1a), as previously demonstrated in fetal liver1. We 
performed RNAseq analysis on sorted erythroid precursors (pro-, basophilic, poly-, and orthochromatophilic 
erythroblasts) from adult male Nan and WT-PHB spleens to identify global transcriptome changes specific to 
Nan-KLF1. Peripheral blood studies confirm that WT-PHB mice develop anemia with significantly decreased 
RBC count, hemoglobin, and hematocrit; and increased RBC and hemoglobin distribution width, reticulocyte 
percentage, and spleen weight (Supplementary Table S1). Cell morphology is similar in Nan and WT-PHB with 
significant anisocytosis and polychromasia (Fig. 1b). Poikilocytosis including fragmented cells is rare. Circulating 
erythroblasts are not seen. Total bilirubin and LDH, indicators of hemolysis, did not differ significantly between 
Nan and WT-PHB (Supplementary Table S1); bilirubin, but not LDH, was increased over WT in both.
We obtained ~36 million mapped reads per sample (3 male mice per genotype with 4 erythroid precursor 
populations each for a total of 24 samples with 3 technical replicates each) and analyzed for differential expres-
sion. The number of differentially expressed genes (DEGs) increases dramatically during differentiation (Table 1), 
likely reflecting progressively increasing Klf1 expression (Fig. 1c; expression profiles can be generated at http://
nanexpression.mdibl.org/). In total, 6,965 unique genes were differentially expressed across the combined pre-
cursor populations. Surprisingly, these overlapped with only 61% of fetal liver DEGs. Analysis of gene ontology 
(GO) terms using DAVID24 by precursor cell type revealed no significant functional annotations (Benjamini 
corrected p-values) associated with pro- and basophilic erythroblasts and just three associated with polychro-
matophilic erythroblasts. A great many, however, emerge in orthochromatophilic erythroblasts including pro-
cesses that could potentially contribute to anemia (translation, RNA processing, cytoskeletal organization, 
apoptosis, oxidation-reduction, cell cycle) (Fig. 1d,e). Indeed, cytoskeletal (membrane skeleton) defects were 
documented previously in Nan1,2. The most significant p-values are associated with down-regulated genes in 
orthochromatophilic erythroblasts, suggesting that failure to engage normal DNA targets, or engaging with 
reduced affinity, is a major consequence of Nan-KLF1 late in differentiation. The complete lists of DEGs in fetal 
liver, DEGs common to fetal liver and spleen, and DEGS in each of the four spleen precursor cell types are given 
in Supplementary Tables S2–S7.
Nan-specific expression differences in fetal liver and spleen. We showed previously that expression 
of Hamp and Irf7 is significantly up-regulated in Nan whole fetal liver and adult whole spleen vs. WT fetal liver 
and spleen15, and confirmed upregulation in fetal liver here (Supplementary Table S2). Importantly, Hamp and 
Irf7 upregulation was confirmed by qRT-PCR in fetal liver cells depleted of adherent cells and expanded in cul-
ture with erythropoietin in previous studies15. These data indicate that Hamp and Irf7 are ectopically activated 
by Nan-KLF1 in fetal liver, as neither is normally expressed in erythroid cells17,18. Here, however, we find no 
Hamp expression in Nan or WT-PHB spleen erythroid precursors (http://nanexpression.mdibl.org/). Thus, Hamp 
expression driven by mutant Nan-KLF1 differs in fetal liver and anemic adult spleen erythroid cells even though 
both are stress environments. On the other hand, Irf7 is expressed at equally high levels in both Nan and WT-PHB 
spleen (Fig. 2a), indicating that Irf7 can also be upregulated as a general consequence of stress erythropoiesis in 
the spleen and is not specific to Nan.
Niche-specific differential expression of Nan β-like globin genes is also seen. Embryonic βh1 (Hbb-bh1) is 
significantly upregulated in Nan vs. WT fetal liver and non-anemic (hereafter WT) spleen1,15. Here however, no 
differential upregulation is seen in adult Nan vs. WT-PHB spleen precursors (Fig. 2b), indicating that increased 
expression in the spleen is due to stress erythropoiesis in response to anemia, as documented previously25,26. βh1 
is expressed at low levels in proerythroblasts and basophilic erythroblasts where the embryonic globin repressor 
Bcl11a is highly expressed in both Nan and WT-PHB (Fig. 2c). Bcl11a expression falls in poly- and orthochro-
matophilic erythroblasts; the decrease is greater in Nan than WT-PHB, but their βh1 expression is equivalent 
in these precursors (Fig. 2b). We confirmed βh1 and Bcl11a expression patterns by qRT-PCR (Fig. 2d). Two 
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Figure 1. Aberrant erythroid transcriptome in adult anemic Nan mice. (a) cDNA sequence chromatograms 
showing transcription of Klf1 alleles in wild type control (WT, +/+) and sorted Nan spleen erythroid cells. Both 
the normal and mutant alleles are equally expressed in Nan throughout terminal differentiation. (b) Peripheral 
blood smears from untreated (non-anemic) WT and phlebotomized WT control (WT-PHB) and Nan adult 
mice. Bars, 10 µM. (c) Expression level (log2 counts) of Klf1 in WT-PHB and Nan spleen erythroid precursors. 
Differences in Klf1 expression do not meet filtering criterion (fold change ≥2, false discovery rate ≤0.05) for 
differentially expressed genes in any of the precursor populations. The graph shows the three technical replicates 
for each of the 3 biological replicates, giving 9 points per genotype per cell type. Tick marks, mean ± SD. (d,e) 
Top functional annotations associated with up- (red) and down- (green) regulated gene expression in Nan 
spleen poly- and orthochromatophilic erythroblasts suggest multiple mechanisms could contribute to anemia 
in Nan. Note: In panel e terms broadly associated with translation and RNA processing are shown separately 
(middle) in order to display other highly significant functional annotations (bottom).
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4Scientific RepoRts |  (2018) 8:12793  | DOI:10.1038/s41598-018-30839-2
additional major silencers of Hbb-bh1 in vivo, Zbtb7a and Myb27,28, are not differentially expressed at any stage 
(Supplemental Fig. 1).
Unexpectedly, βh2 (Hbb-bh2) is upregulated dramatically in Nan spleen – reaching 534-fold in orthochro-
matophilic erythroblasts; no or little expression is seen in WT-PHB spleen (Fig. 2e). This result was verified by 
qRT-PCR (Fig. 2f) confirming an altered effect of Nan-KLF1 at this locus. Comparing transcript read numbers, 
Nan βh2 comprises 0.34% and WT-PHB just 0.001% of total β-like globin in orthochromatophilic erythroblasts 
(Supplementary Table S8). No differential expression of βh2 is seen in fetal liver. Adult β-globin expression is 
delayed in Nan spleen compared to WT-PHB; β-globin is decreased at the pro- and basophilic erythroblast stages 
but recovers by the poly- and orthochromatophilic stages (Fig. 2g).
Patterns of gene expression in Nan. We generated pairwise correlations of all samples using a reduced 
set (~8,600) of high variance genes. Hierarchical clustering based on these correlations shows that expression 
differences are much more severe in late (poly- and orthochromatophilic) than in early (pro- and basophilic) 
erythroblasts (Fig. 3a), confirming that progression of differentiation contributes a major source of expression 
variation. Indeed, PCA of the spleen expression matrix reveals that the first principle component (PC1) is dom-
inated by cell type, whereas PC2 separates the samples within each cell type by genotype with modest effect of 
cell type at the pro- and basophilic stages but significantly more dramatic effects at the poly- and, particularly, 
the orthochromatophilic stages (Fig. 3b). PC1 and PC2 account for 59.5% and 13.9% of expression variation, 
respectively. The PCA confirms the role of cellular differentiation in driving expression variation as terminal dif-
ferentiation proceeds with Nan-KLF1 driving increasingly aberrant transcription in later stages of differentiation.
When each PC is plotted separately as a function of genotype and precursor cell type, two major patterns 
of gene expression emerge in terms of how expression changes during differentiation from pro- to orthochro-
matophilic erythroblasts in WT-PHB precursors, and how expression diverges from WT-PHB in Nan precur-
sors. Because PCA groups genes by their correlation with the components and represents both correlated and 
anti-correlated patterns, complimentary patterns of expression (meaning both increasing and decreasing) are 
included within each PC. Thus, the PC1 expression pattern is one of gradual, progressive change in expression 
in WT-PHB (either increasing or decreasing steadily) during differentiation, while expression in Nan shows a 
parallel overall course but progressively diverges from WT-PHB during differentiation such that expression dif-
ferences are most prominent in poly- and orthochromatophilic erythroblasts (Fig. 3c, top panel). Examples of 
PC1-positively correlated genes (expression decreases during differentiation) include Sf3b3 (splicing factor 3b, 
subunit 3) (Fig. 3d) and Steap3 (STEAP family member 3) (Fig. 3e). Epor (erythropoietin receptor) exemplifies a 
PC1-negatively correlated gene (expression increases during differentiation) (Fig. 3f).
In the second expression pattern, that for PC2, expression in WT-PHB trends consistently up or down as 
differentiation proceeds (Fig. 3c, bottom panel). In Nan, expression is consistently higher or lower than WT-PHB 
at all stages and follows the same overall trend (either increasing or decreasing with differentiation) until the 
orthochromatophilic erythroblast stage, where a sharp, often dramatic reversal occurs in Nan (Fig. 3c, bottom 
panel). Moreover, while the direction of the differential expression in Nan is constant, the magnitude generally 
increases during differentiation. Thus, PC2-correlated genes show more severe dysregulation throughout differ-
entiation in Nan. Prdx3 (peroxiredoxin 3) is positively correlated with PC2 and its expression increases with dif-
ferentiation; Snx4 (sorting nexin 4) and Ctnnb1 (beta catenin) are negatively correlated (Fig. 3g–i) and expression 
decreases. The complete list of genes correlated with PC1 and PC2 is provided in Supplementary Table S9.
We predict that the overall functional output of the altered Nan transcriptome will be most influenced by 
genes highly correlated with PC2, where Nan expression diverges the greatest throughout terminal differentia-
tion, and to a lesser degree, PC1. For genes with the most significant negative correlations with PC1 (expression 
increases during differentiation), the top GO functional annotations include ubiquitination, autophagy/mito-
phagy, cell cycle, transcription, and erythroid differentiation (Fig. 4a). Conversely, the top annotations for the 
most significant PC1 positively correlated genes (expression decreases) are dominated by terms related to trans-
lation and mRNA processing. As PC1 is driven largely by cell type with little mutation effect, these up- and down 
changes in gene expression are consistent with major processes occurring during normal terminal differentiation. 
For PC2, where mutation effects dominate, protein transport, transcription and translation are the most signif-
icant GO functional annotations for positively correlated genes (expression increases); for negatively correlated 
genes (expression decreases) cell cycle, cell division, oxidation-reduction, and DNA repair dominate (Fig. 4b).
Erythropoiesis in Nan. Previous studies revealed membrane skeleton defects and impaired globin expres-
sion in Nan. Here, based upon striking differential expression and predictions arising from PCA, we tested the 
hypothesis that additional processes go awry and contribute to anemia in Nan. We first examined erythropoiesis 
in Nan compared to both anemic and non-anemic WT spleen and bone marrow to achieve a full picture of 
erythroid status in Nan. Significantly, unlike KLF1-null mice8, expression of cell surface markers used to assess 
erythropoiesis by flow cytometry (Ter119, CD71, CD44) is normal or near normal in Nan (Supplemental Fig. 2).
Pro Baso Poly Ortho
DEGs 1040 1659 2679 5125
Up-regulated 505 860 1438 2209
Down-regulated 535 799 1241 2916
Table 1. Differentially expressed genes in Nan spleen erythroid precursors*. *FC ≥ 2, FDR = 0.05.
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Figure 2. Nan- and erythroid niche-specific expression changes. Expression of (a) Irf7 and (b) Hbb-bh1 is 
not differentially regulated in Nan vs. WT-PHB spleen erythroid precursor cells while both are markedly 
upregulated in Nan fetal liver (fold change in Nan fetal liver from Supplemental Table 2 in blue). (c) Expression 
of Bcl11a. Fold change vs. WT-PHB in blue. (d) Confirmation of Hbb-bh1 (top) and Bcl11a (bottom) 
expression by quantitative RT-PCR. AU, arbitrary units, no significant differences. n = 3 for Nan and WT-
PHB. (e) Hbb-bh2 is progressively upregulated during erythropoiesis in Nan, reaching a 534-fold increase at 
the orthochromatophilic stage. (f) Confirmation of dramatically up-regulated Hbb-bh2 expression in Nan 
by quantitative RT-PCR. Average values for WT-PHB are shown in blue to facilitate comparison to Nan. AU, 
arbitrary units; *p < 0.01 and **< 0.001 Nan vs. WT-PHB. n = 5 (Nan) and 6 (WT-PHB) except Ortho (n = 2 
and 3, respectively). (g) Adult β-globin, Hbb-bs, is downregulated in Nan pro- and basophilic erythroblasts. 
The duplicated adult globin locus, Hbb-bt, shows the same pattern (http://nanexpression.mdibl.org/). Neither 
Hbb-bh2 nor Hbb-bt are differentially expressed in Nan whole fetal liver. Tick marks, mean ± SD. Note: 
All expression values are log2-transformed, normalized counts; therefore, values below 1 are considered 
background (no expression).
www.nature.com/scientificreports/
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Figure 3. Principle component analysis (PCA). (a) Hierarchical clustering showing that expression differences 
are greatest in later stages of development (poly- and orthochromatophilic erythroblasts). (b) The first PC 
is dominated by cell type and accounts for 59.5% of the variation in expression while PC2 (13.9%) separates 
the samples within each cell type by genotype. (c) PC1 (top) and PC2 (bottom) plotted by genotype as 
differentiation proceeds from pro- orthochromatophilic erythroblasts reveal two major patterns of differential 
expression in Nan. (d) Sf3b3 (splicing factor 3b, subunit 3) and (e) Steap3 (STEAP family member 3) are 
positively, and (f) Epor (erythropoietin receptor) negatively correlated with PC1 where the most prominent 
expression differences are late in differentiation at the orthochromatophilic stage. (g) Prdx3 (Peroxiredoxin 3) 
is negatively correlated with PC2 while (h) Snx4 (Sorting nexin-4) and (i) Ctnnb1 (β-catenin) are positively 
correlated with PC2. Genes correlated with PC2 show severe dysregulation throughout differentiation in Nan 
with a striking reversal at the orthochromatophilic stage. Tick marks, X ± SD.
www.nature.com/scientificreports/
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Spleen total cell counts (Fig. 5a) are significantly higher in Nan and WT-PHB vs. WT, as expected due to 
anemia. Non-erythroid (CD45+) cells are significantly increased in WT-PHB but not Nan compared to WT. 
Erythroid cell (CD45−) counts are increased approximately two-fold over WT in Nan and WT-PHB, but do not 
reach statistical significance. Nan erythroid cell counts showed more variability than WT and WT-PHB, over-
lapping WT in many cases (Supplemental Fig. 3), suggesting that stress erythropoiesis is inefficient to varying 
degrees in Nan mice. Bone marrow counts do not differ among the three groups (Fig. 5a).
Flow-cytometric analysis of differentiation29 revealed significantly delayed progression of erythropoiesis in 
Nan spleen, with cells accumulating at the proerythroblast stage compared to WT and at the baso- and poly-
chromatophilic stages compared to both WT and WT-PHB (Fig. 5b). Orthochromatophilic erythroblasts are 
significantly increased in Nan compared to WT, but strikingly depleted compared to WT-PHB (Fig. 5b), as is 
also evident upon inspection of flow cytograms (Supplemental Fig. 4). The accumulation of earlier precursors 
with striking depletion of late orthochromatophilic erythroblasts in Nan vs. WT-PHB, where a progressive and 
dramatic increase in the percentages of each successive cell type is seen throughout differentiation, again suggests 
suboptimal stress erythropoiesis in Nan. A significant delay in erythropoiesis also occurs at the baso- and poly-
chromatophilic stages in Nan bone marrow with depletion of orthochromatophilic erythroblasts compared to 
WT-PHB mice (Fig. 5b). These results confirm highly disordered basal and stress erythropoiesis in Nan.
Cell cycle. We asked if cell cycle defects contribute to accumulation of precursors and delayed progression of 
maturation in Nan. Both Nan and WT-PHB spleen proerythroblasts, which do not differ from each other, show 
evidence of accelerated cell cycling compared to WT; the percentage of proerythroblasts in G0/G1 is signifi-
cantly decreased and the percentage in S phase significantly increased (Fig. 6a). This pattern was not maintained, 
however, in subsequent precursors. In WT-PHB, no further differences except a small but significant increase in 
orthochromatophilic erythroblasts in S phase is seen. As expected, nearly all orthochromatophilic erythroblasts 
have exited the cell cycle. The percentage of Nan bone marrow polychromatophilic erythroblasts in G2M is sig-
nificantly higher than WT-PHB but does not differ from WT (Fig. 6a). Thus, with the possible exception of spleen 
Figure 4. Functional annotation GO terms for PC1- and PC2- correlated DEGs. Top functional annotations 
associated with (a) PC1 and (b) PC2 DEGs. Genes negatively correlated with each PC are shown at the top in 
red and those positively correlated below in green. Note that correlation and expression are inversely related 
for PC1 genes (e.g., expression of negatively correlated genes increases during differentiation), but directly 
related in the case of PC2 (refer to Fig. 3c). Red and green also correspond to up- and down-regulated DEGs, 
respectively, in Nan. For this analysis, only the most significantly correlated genes (Supplemental Table 9) were 
included. For PC1, a cutoff of ±0.9 was used. For PC2, the cutoffs were −0.60 and +0.75 for negatively and 
positively correlated genes, respectively. Expanded correlation values were included for PC2 GO analysis due to 
the lower number of genes in this category.
www.nature.com/scientificreports/
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proerythroblasts, delayed differentiation with accumulation of precursors in Nan (Fig. 5) cannot be explained by 
cell cycle changes.
Apoptosis. The percentage of apoptotic proerythroblasts in both WT and Nan spleen is dramatically and 
significantly higher than WT-PHB (Fig. 6b). Apoptotic basophilic erythroblasts are also higher in WT and Nan 
vs. WT-PHB, but do not reach statistical significance in Nan. Notably, apoptosis in Nan does not differ from WT 
in any spleen precursor population. Apoptosis in WT-PHB spleen is maintained at a low and consistent level 
throughout terminal differentiation in the spleen, while early precursors in Nan undergo significant apoptosis. 
Thus, a high percentage of pro-and basophilic erythroblasts are lost in the Nan spleen when increased RBC pro-
duction is needed.
Figure 5. Erythropoiesis is delayed in Nan spleen. (a) Total, CD45 positive and CD45 negative cell counts in 
WT, Nan, and WT-PHB spleen (n = 3, 10, and 4, respectively) and bone marrow (n = 4/group). (b) Quantitation 
of the different spleen populations demonstrates an accumulation of pro-, baso and- polychromatophilic 
erythroblasts in Nan spleen (top panel) and baso- and- polychromatophilic erythroblasts in Nan bone marrow 
(bottom). As a result, production of orthochromatophilic erythroblasts markedly lags that of WT-PHB. n = 4/
group. *P < 0.05; **p < 0.01; ***p < 0.001.
www.nature.com/scientificreports/
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In bone marrow, apoptotic Nan and WT-PHB pro- and basophilic erythroblasts do not differ from each other 
but are significantly less than WT (Fig. 6b). Apoptosis in Nan poly- and orthochromatophilic erythroblasts is 
decreased relative WT.
ROS generation, mitophagy. To measure ROS, we utilized peroxide- and superoxide-sensitive fluores-
cent dyes, DCF and DHE, respectively. Preliminary studies suggested increased ROS generation in Nan whole 
blood; subsequent analyses were done on CD71 and Ter119 stained whole blood to obtain quantitative data on 
Figure 6. Cell cycle status and apoptosis in spleen and bone marrow. (a) Cell cycle status determined using 
BrdU in spleen (top) and bone marrow (bottom) erythroid precursors. Spleen, n = 6 (WT), 8 (Nan), 9 
(WT-PHB); bone marrow, n = 3/group. (b) Apoptosis in spleen (top) and bone marrow (bottom) erythroid 
precursors. Spleen, n = 9 (WT), 10 (Nan), 7 (WT-PHB); bone marrow, n = 3 per group. *P < 0.05; **p < 0.01; 
***p < 0.001.
www.nature.com/scientificreports/
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enriched reticulocyte (CD71hi) and mature erythrocyte (CD71lo) fractions (Supplemental Fig. 5). Superoxide and 
peroxide generation is increased in Nan mature erythrocytes compared to WT and WT-PHB (Fig. 7A). In Nan 
reticulocytes peroxide generation did not differ significantly from WT but was significantly less than WT-PHB. 
Reticulocyte superoxide generation in Nan and WT-PHB did not differ but both were increased compared to WT 
(Fig. 7A).
Increased ROS production can result from increased mitochondrial content due to defective mitophagy. 
Hence, we examined RBC mitochondria and ribosome content using MitoTracker Red and Thiazole Orange 
(Fig. 7B). A small increase in retained mitochondria is seen in Nan compared to WT (1.5 ± 0.8 vs. 0.2 ± 0.2, X 
±SD, n = 3) although the difference was not statistically significant. Thus, increased ROS production without 
significant mitochondria retention contributes to hemolysis in Nan.
DNA damage. We examined DNA damage using a flow-cytometric peripheral blood micronucleus (MN) 
assay, which provides a quantitative measure of both spontaneous and radiation induced chromosome dam-
age30,31. A small, but significant, increase in Nan reticulocyte MN is seen 48 hours post-irradiation (Fig. 7C,D), 
returning to baseline (time 0) at 72 hours. A similar pattern, although exaggerated compared to Nan, is seen in 
WT-PHB. The exaggerated response in WT-PHB may be due to acute induction of anemia in this group. Overall, 
these data indicate that WT-PHB and Nan are more susceptible to induced MN formation vs. WT; however, the 
DNA damage response is intact, as reticulocyte MN returned to baseline at 72 hours in both. RBC MN, indicative 
of spontaneous damage, did not change pre-and post-irradiation, as expected (not shown).
Discussion
Prior studies revealed that Nan-KLF1 acts as both a hypomorphic and neomorphic allele, failing to bind a sub-
set of normal KLF1 target genes while inappropriately engaging non-KLF1 targets13. The result is a corrupted 
transcriptome that produces anemia by both cell intrinsic and extrinsic mechanisms15. Nan is relevant to human 
disease where a mutation at the corresponding position causes CDA type IV; the different mouse-human anemia 
phenotype may reflect the different amino acid changes.
Here, we compared adult Nan and WT-PHB sorted spleen erythroid precursors as a way to discern effects on 
gene expression specific to Nan-KLF1 induced anemia. We chose phlebotomy-induced anemia over phenylhy-
drazine treatment to avoid confounding factors induced by phenylhydrazine such as widespread oxidative dam-
age, severe hemolysis, and near 100% reticulocytosis. RNAseq revealed progressively increasing transcriptome 
changes in Nan during erythroid differentiation. PCA revealed that PC1 was dominated by cell type, contributing 
60% of the expression variation. PC2, dominated by genotype effects, contributed 14% with strongest effects in 
poly- and orthochromatophilic cells reflecting increasing mutant Klf1 expression during differentiation. In total, 
6,965 unique genes were differentially expressed with only a subset overlapping those identified in fetal liver.
We assessed overall functional effects of the extensive global transcriptome changes in the context of the whole 
animal. We first examined erythropoiesis by flow cytometry and found evidence of suboptimal stress erythro-
poiesis in Nan. Increased percentages of all erythroid precursors are seen in WT-PHB compared to WT spleen, as 
expected during stress erythropoiesis in response to anemia. Nan, however, shows a significant accumulation of 
pro-, baso-, and polychromatophilic erythroblasts compared to WT, and a significant accumulation of baso- and 
polychromatophilic erythroblasts in conjunction with a severe decrement of orthochromatophilic erythroblasts 
compared to WT-PHB. These data suggest that progression though the final stages of differentiation fails in a 
significant portion of Nan precursors, results concordant with analyses of KLF1-null fetal liver erythroblasts32. 
Strikingly, erythropoiesis in the Nan bone marrow shows the same overall pattern where a significant accumula-
tion of polychromatophilic over orthochromatophilic cells is also evident. Despite the decrement in orthochro-
matophilic erythroblasts in Nan, reticulocytosis is significantly elevated, possibly due to slower maturation or 
faster kinetics in reaching the peripheral circulation over WT, or both. Whether the latter occurs at the level of 
enucleation and/or extrusion from the bone marrow and spleen remains to be elucidated. Nonetheless, total cir-
culating RBCs (reticulocytes plus mature erythrocytes) are significantly decreased in Nan.
Two major patterns of expression divergence between WT-PHB and Nan during differentiation emerged when 
each PC was plotted individually as a function of cell type and genotype (Fig. 3c). Compared to PC1, PC2 show 
relatively greater divergence of expression in Nan precursors, particularly late precursors. Using top functional 
annotation GO terms associated with PC2 as a starting point, we identified processes including cell cycle, DNA 
damage, and apoptosis that could contribute to anemia with delayed progression of erythropoiesis and/or subop-
timal stress erythropoiesis in Nan for functional screening. In terms of the cell cycle, significant changes indicative 
of increased cell cycle progression were detected in Nan and WT-PHB proerythroblasts compared to WT but were 
not maintained in later precursors. Overall, cell cycle changes fail to account for disordered erythropoiesis in Nan. 
Likewise, although Nan appears more susceptible to induced DNA damage, the DNA damage response is intact.
Interestingly, differences in apoptosis could at least partially underlie suboptimal stress erythropoiesis in Nan. 
Previous studies33 demonstrated that stress-responsive pro- and basophilic erythroblasts undergo a high rate 
of apoptosis in non-anemic WT mice, and that this response is suppressed in anemic mice under the influence 
of erythropoietin (Epo). Here, greater than 60% of WT spleen proerythroblasts and nearly 30% of basophilic 
erythroblasts are apoptotic; spleen apoptosis in early WT-PHB precursors, most strikingly proerythroblasts, is 
markedly decreased compared to WT (Fig. 6b). In Nan, despite anemia accompanied by high serum erythro-
poietin (Epo) levels15 and normal Epor expression in stress-responsive precursors (Fig. 3i; nanexpression.mdibl.
org), apoptosis is inappropriately high, not differing significantly from WT. Epo-responsive mechanisms medi-
ating suppression of apoptosis in anemia and facilitating erythroid expansion during stress in WT mice include 
downregulation of cell-surface expression of apoptosis-promoting Fas and FasL, and induction of anti-apoptotic 
Bcl-xL33–35. Bcl2l1 encoding Bcl-xL is also a well described direct KLF1 target gene36. KLF1 and STAT5 likely direct 
expression of Bcl2l1 via independent intronic enhancers35. Neither Fas nor FasL are expressed in WT-PHB or 
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Figure 7. ROS generation, mitophagy, and DNA damage in Nan. (A) Quantitation of ROS production in 
Ter119 positive, CD71 low (mature red blood cells) and Ter119 positive CD71 high (reticulocytes) populations. 
As expected, DCF and DHE production in mature red cells is lower than in reticulocytes43. n = 3 per group. (B) 
Flow cytometry of MitoTracker Red (MTR) and Thiazole Orange (TO) stained WT and Nan red blood cells 
to assess mitochondria and ribosome content three days post-phlebotomy. Early reticulocytes are ribosome-
positive, mitochondria-positive (upper right quadrant), late reticulocytes ribosome-positive, mitochondria-
negative (lower right quadrant), and retained mitochondria ribosome-negative, mitochondria- positive (upper 
left quadrant). Cytograms representative of 3 samples/group. (C) Representative micronucleus assay results in 
non-irradiated mice. (D) Quantitation of induced micronuclei 48 and 72 hours following irradiation. n = 4 per 
group; ***p < 0.001 (within group comparison at 0 and 48 hours). PI, propidium iodide.
www.nature.com/scientificreports/
1 2Scientific RepoRts |  (2018) 8:12793  | DOI:10.1038/s41598-018-30839-2
Nan early erythroblasts and, therefore, cannot account for the observed differences in apoptosis. Similarly, Bcl2l1 
is not differentially expressed in Nan pro- and basophilic erythroblasts, although expression is decreased slightly 
(nanexpression.mdibl.org). Nonetheless, unless decreased Bcl2l1 expression in Nan to levels considerably below 
our criteria for statistical significance (absolute fold change >2, p < 0.05) affects apoptosis, Bcl-xL seems unlikely 
to mediate failure to downregulate apoptosis in early Nan precursors. In general, inappropriate up-regulation of 
pro-apoptotic genes in Nan, or inappropriate down-regulation of anti-apoptotic genes, could account for failure 
to suppress apoptosis. Of the many other anti-apoptotic genes in addition to Bcl2l1 that are expressed in eryth-
roid precursors (Bcl2, Mcl1, Bcl2l2, Bcl2L10), none are downregulated in Nan pro- and basophilic erythroblasts. 
Likewise, none of the major pro-apoptotic genes37–39 expressed in erythroid precursors including Bax, Bak1, 
Bok, Bid, Bcl211 (BIM), Bbc3 (PUMA), Bad, Pmaip1 (NOXA) or Hrk are significantly upregulated in Nan. Thus, 
although apoptosis clearly plays a role in stress erythropoiesis, what drives the different apoptotic rates in Nan 
vs. WT-PHB spleen precursors is presently unknown. Elucidating mechanisms underlying the inadequate stress 
response in Nan will require additional study.
ROS is generated in RBCs primarily through the autooxidation of oxyhemoglobin, which produces super-
oxide ions40. Increased ROS generation is seen in Nan and WT-PHB peripheral blood cells, although the major 
species and relative amounts produced differ in Nan vs. WT-PHB reticulocytes and mature red blood cells 
(Fig. 7A). Increased ROS causes or exacerbates anemia via oxidative damage to membranes causing hemolysis 
and decreased erythrocyte lifespan. To combat the deleterious effects of ROS, red cells rely on superoxide dis-
mutases to convert superoxide to hydrogen peroxide, which is then scavenged by peroxiredoxins, catalase, and 
glutathione peroxidase40–42. Of the major antioxidants at work in the red cell, the peroxiredoxins (Prdx1/2) and 
superoxide dismutase (Sod2) are well characterized in terms of their null phenotypes leading to increased RBC 
ROS generation and hemolytic anemia in mice41–44. In Nan, expression of Prdx1 and Prdx2 is erythroid precur-
sors is decreased, but not significantly. Notably, Prdx3, 4, 5, and 6 are robustly expressed in anemic erythroid 
precursors. Prdx5 is not differentially expressed, but expression of both Prdx3 and 4 is decreased 3.4 fold in Nan 
orthochromatophilic erythroblasts, and expression of Prdx6 is increased in both poly- (2.8- fold) and orthochro-
matophilic (2.5-fold) erythroblasts. Mice null for Prdx3 and 4 are associated with increased oxidative stress in 
adipose45 and testis46, respectively, but a role for these peroxiredoxins, or for Prdx5 and 6, in erythrocytes has not 
previously been noted to our knowledge. We hypothesize that these peroxiredoxins, like Prdx1 and 2, play a role 
in oxidant defense in RBCs, and that their dysregulated expression may contribute to anema in Nan Similarly, 
four glutathione peroxidase genes, Gpx1, 3, 4, and 7 are expressed in anemic spleen, and all but Gpx1 are dysregu-
lated in Nan. Thus, these and other proteins involved in red cell oxidant defense could contribute as well.
Interestingly, functional annotations relevant to ribosomes and translation dominate PC1 genes whose expres-
sion decreases with differentiation. Indeed, an extensive list of, large (Rpl−) and small (Rps−) ribosomal subunit 
genes are differentially expressed, mostly downregulated, in Nan (Supplementary Table S10). Despite this, no 
evidence of ribosomopathy is seen. Haploinsufficiency of twenty ribosomal subunit genes is known or suspected 
to cause the inherited bone marrow failure syndrome, Diamond Blackfan anemia (DBA)47, and all of but two of 
these genes are downregulated in Nan. For example, Rps19, the cause of 25% of DBA cases, is decreased >six-fold. 
However, Nan bone marrow is normocellular without any decrement in erythroid precursors47–50, peripheral 
RBCs are microcytic, and reticulocyte production is elevated, all inconsistent with DBA or other bone failure 
syndromes.
Despite large fold changes in many genes associated with specific cellular processes, such as translation, func-
tion is maintained. Large numbers of GO terms associated with cell cycle, as another example, are found in both 
the up-and down-regulated gene lists in all precursors (Supplementary Table S11), but significant detectable 
consequences in Nan are few. Thus, tolerance to expression variation is high, at least in the context of the red cell. 
Possibly, absolute expression remains sufficient to maintain function. Also, expression changes that are the direct 
consequence of Nan-KLF1 would be expected to cause indirect downstream effects on other genes; these could 
compensate for Nan-KLF1 induced changes and allow the most critical basic cellular functions to remain intact, 
leading to physiological resiliency in developing red cells in vivo. Future studies will be needed to determine the 
extent to which expression tolerance is reflected at the posttranscriptional level.
Methods
Animals. All mice were maintained at The Jackson Laboratory in climate- and light cycle-controlled rooms. 
Acidified water and 5K52 chow (PMI LabDiet) were provided ad libitum. Nan is a fully inbred strain. The original 
mutant Nan mouse was a female offspring of an ENU–mutagenized C3H/101 F1 male and a “PT” female at the 
Medical Research Council, Harwell, U.K. The PT stock was a mixed-background mutation-testing stock. The 
anemic female was mated to an untreated C3H/101 F1 male, and the mutation was propagated by intercrossing 
offspring1,2. Nan was imported to the Jackson Laboratory in 1994 and maintained in the research colony of Dr. 
Luanne Peters by brother-sister matings for more than 20 generations. Hence, according to mouse nomenclature 
rules (http://www.informatics.jax.org/mgihome/nomen/), the original Harwell Nan stock used in this study is a 
fully inbred subline designated NAN/Llp. The official designations for homozygous, heterozygotes and WT litter-
mates are NAN/Llp Klf1Nan/Klf1Nan, NAN/Llp Klf1Nan/Klf1+, and NAN/Llp Klf1+/Klf1+, respectively. All experi-
ments were carried out in accordance with National Institutes of Health Laboratory Animal Care Guidelines and 
were approved by the Animal Care and Use Committee (ACUC) of the Jackson Laboratory.
Phlebotomy. Adult WT littermates were phlebotomized via daily retro-orbital collection of ~350 μL whole 
blood followed immediately by intraperitoneal injection of sterile normal saline (37 °C) for four days.
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Peripheral blood studies. Complete blood counts were determined using a Siemens Advia 120 analyzer. 
Blood smears were stained with Wright-Giemsa (Sigma-Aldrich). Serum lactate dehydrogenase (LDH) and bili-
rubin levels were determined using a Beckman AU680 analyzer.
Sorting of erythroid precursors. Single cell suspensions of adult (6–8 weeks) whole spleens were 
depleted of CD45+ cells using mouse CD45 MicroBeads (Miltenyi Biotec), stained (CD45-FITC, Ter119-PE and 
CD44-APC), and sorted on a FACSAria II flow cytometer (BD Biosciences) as described29.
RNAseq. Total RNA was extracted with the PureLink RNA Mini Kit (Invitrogen) and libraries prepared using 
the KAPA mRNA HyperPrep Kit (KAPA Biosystems), according to the manufacturer’s instructions. Briefly, the 
protocol entails isolation of polyA containing mRNA using oligo-dT magnetic beads, RNA fragmentation, first 
and second strand cDNA synthesis, ligation of Illumina-specific adapters containing a unique barcode sequence 
for each library, and PCR amplification. Libraries were checked for quality and concentration using the D5000 
ScreenTape assay (Agilent Technologies) and quantitative PCR (KAPA Biosystems), according to the manufac-
turer’s nstructions. Paired end sequencing was performed on the HiSeq2500 System using TruSeq SBS Kit v4 
reagents (Illumina). Reads were aligned to mouse genome GRCm38 with STAR Aligner51. Quality control was 
performed with RSeQC52,53 and Picard (http://broadinstitute.github.io/picard/). Quantification to the mouse 
transcriptome ENSEMBL v85 was implemented using Gencode version M1054. Count matrix normalization (rlog 
transformation) and differential expression analysis was performed with DESeq255. Differential expression anal-
ysis was performed on unnormalized counts assigned to each gene rather than FPKM (Fragments Per Kilobase 
of gene per Million reads), as recommended for DESeq2. Differentially expressed genes were extracted from 
DESeq2 output files using threshold values of ≥2 absolute fold change and ≤0.05 adjusted p-value.
Previously obtained fetal liver RNAseq data13 (SRA SRP061646, GEO GSE71396) was re-analyzed as above to 
facilitate valid comparisons between datasets.
To examine global patterns, further analysis was performed on the rlog regularized matrix.
The regularized matrix was further Z-transformed by the function Z = (exp − avg)/stdev, where avg and stdev 
are the average and sample standard deviation of the regularized expression level of each gene across all samples. 
To focus the analysis on genes with appreciable expression and/or variation, the matrix was reduced from all 
45,232 annotated genes to 8,668 with avg ≥ 5.0 or stdev ≥ 2.0. Principal Components Analysis was performed 
using default parameters with JMP v11.2.1 (SAS Institute) on the transpose of the reduced Z-transformed expres-
sion matrix. Gene ontology (GO) term searches were performed with DAVID v6.8 (default settings)24.
Sanger sequencing. cDNA was synthesized using the Ambion MessageSensor RT kit and Invitrogen ran-
dom decamer primers (Invitrogen). PCR was performed using Invitrogen Platinum SuperFi PCR Master Mix 
(Invitrogen) with an annealing temperature of 65 °C. Klf1 forward (5′-AGACGCAGGCTTGTCCCCGGGAACT) 
and reverse (5′-GCAGGATCACTCAGAGGTGACGCTT) primers were in exons 2 and 3, respectively, and 
spanned the Nan mutation. PCR products are purified using MagBIO’s HighPrep PCR magnetic beads. 
Sequencing was performed using Applied Biosystems BigDye Terminator ready reaction kit Version 3.1, run on 
an Applied Biosystems 3730xl, and analyzed using Applied Biosystems Sequencing Analysis software version 5.2.
Quantitative real-time RT-PCR (qRT-PCR). cDNA was prepared as above. qRT‐PCR reactions consisted 
of 4.5 μl of cDNA, 5 μl of TaqMan Gene Expression Master Mix and 0.5 μl of primers and probes (TaqMan® gene 
expression assay, assay ID: Hbb-bh1, Mm00433932_g1; Hbb-bh2, Mm01273444_g1; Bcl11a, Mm00479358_m1) 
(Applied Biosystems). Samples were prepared in triplicate. qRT-PCR was performed using a ViiA7 Real-Time 
PCR System (Applied Biosystems) (40 cycles at 95 °C for 15 sec and 60 °C for 1 min). The relative quantification of 
each gene was determined by the 2−∆∆CT method using control CT values and Gapdh (TaqMan® gene expression 
assay ID: Mn99999915_g1) expression for normalization.
Erythropoiesis, cell cycle and apoptosis. Terminal erythroid differentiation was monitored using CD44, 
Ter119, and forward scatter as described29 and analyzed using a LSRFortessa and FlowJo v9.9.4 software. Cell 
cycle and apoptosis were analyzed using BD Bioscience’s APC BrdU Flow Kit and Annexin V56, respectively, per 
manufacturer’s instructions.
ROS production, mitophagy and DNA damage. Intracellular ROS accumulation was determined 
using chloromethyl, dichlorodihydrofluorescein diacetate (M-H2DCFDA) and dihydroethidium (DHE) 
(ThermoFisher) as described43. Samples were analyzed on a FACSymphony A5 flow cytometer (BD Biosciences) 
and FlowJo v9.9.4. Mitophagy was assessed using Mitotracker Red CMXRos (MTR; Molecular Probes) and thi-
azole orange (TO, BD Biosciences) as described57. DNA damage was assessed by micronucleus assay at baseline 
and following irradiation as previously described30,31. Micronuclei (MN) arise from chromosomes or chromo-
some fragments that are not incorporated into the nucleus during cell division and remain in peripheral blood 
cells. As reticulocytes arise following the last mitosis, radiation induced chromosome damage is detected as an 
increase in reticulocyte MN. Intrinsic or spontaneous damage is seen as an increase in MN in mature red cells, 
which do not contain a nucleus at the time of irradiation.
Data Acquisition and Imaging. Images of peripheral blood were acquired using a Nikon Eclipse E600 
microscope equipped with a Nikon DS-Fi3 color camera and NIS-Elements Documentation imaging software 
(Nikon). Smears were examined with a 100/0.5–1.3 oil-immersion objective.
Statistics. Significant differences were identified using Tukey honestly significant differences (HSD) or 
2-tailed Student t test using JMP Statistical Software v11.2.1.
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Data Deposition. RNAseq data were submitted to Sequence Read Archive (Bioproject PRJNA432205). 
Expression profiles are available at http://nanexpression.mdibl.org/).
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